<DOC>
	<DOCNO>NCT02755103</DOCNO>
	<brief_summary>The current study modify already exist therapy individual substance use disorder address Post Traumatic Stress Disorder ( PTSD ) woman enrol substance use disorder ( SUD ) treatment suffer PTSD SUD . Mindfulness meditation show help individual cope stress regulate emotion . Through meditation practice woman experience less distress relate PTSD symptom reduce substance use response emotional trigger . Women enrol intensive SUD treatment community program randomize receive either 8 week 90 minute Mindfulness Based Relapse Prevention ( MBRP ) group session plus treatment usual ( TAU ) TAU alone . The MBRP group session replace 90 minute TAU group therapy . Measures feasibility implementation , acceptance adherence obtain . Preliminary efficacy substance use PTSD symptom severity measure post treatment 3- 6- month ' follow-up .</brief_summary>
	<brief_title>Mindfulness Meditation Treatment Women With Comorbid PTSD SUD</brief_title>
	<detailed_description>This randomize control pilot study evaluate feasibility preliminary efficacy MBRP plus usual community treatment usual ( TAU ) compare TAU alone ( TAU ) woman substance use disorder ( SUD ) PTSD enrol community substance abuse treatment . Participants randomize eight weekly 90-minute , mixed individual group-based MBRP addition TAU TAU alone . The eight session MBRP replace 8 session seek safety ( SS ) ; trauma focus integrate therapy currently implement TAU . Outcomes assess : 1 . PTSD symptom severity measure Clinician 's Administered PTSD Scale ( CAPS ) Post Traumatic Stress Disorder Symptom Scale-Self Report ( PSS-SR ) ; 2 . Alcohol substance use measure Timeline Follow Back ( TLFB ) assessment corroborate urine drug screen . 3. psychosocial functioning ; 4 . Measure emotional regulation mindfulness awareness , attention acceptance . Recruitment participant primarily take place community treatment program treat woman co-occurring PTSD SUD . Following therapist training , certification piloting , eligible woman invite participate study . Interested potential participant screen major inclusion/exclusion criterion include age , alcohol/substance use , history trauma psychiatric/health/medication status . If potentially eligible , Institutional Review Board ( IRB ) approve informed consent obtain participant schedule baseline assessment appointment . If individual ineligible participate research protocol , continue usual community treatment program and/or indicate , refer additional treatment service . The investigator decide limit study group woman represent large percentage patient comorbid PTSD SUDs experience sexual and/or physical trauma . So trauma-focused treatment deliver group set population , single sex group create safe , comfortable open atmosphere require MM-based treatment trauma focus work . After least 7 day standard treatment baseline assessment collect . Women meet inclusion exclusionary criterion randomize MBRP plus TAU TAU alone control . Both group attend standard intensive TAU program . The eight MBRP therapy session integrate standard TAU program replace 8 TAU SS session . Participants introduce therapist schedule first individual/small group session . The primary outcome measure efficacy portion study 1 ) effective reduction PTSD symptom severity total score CAPS end treatment two study group 2 ) effective reduction proportion day use amount use alcohol/substances final 30 day treatment measure TLFB verify urine drug screen ( UDS ) . In addition , secondary endpoint include CAPS score 3 6 month post-intervention follow-up visit , 7 day point prevalence abstinence rate treatment , post treatment follow visit . Also , PSS-SR , Obsessive Compulsive Drinking Substance Use Scale-Revised ( OCDS-R ) , Addiction Severity Index-Lite ( ASI-Lite ) , Difficulties Emotional Regulation Scale ( DERS ) , Mindfulness Acceptance Awareness Questionnaire ( MAAS ) , Five Facet Mindfulness Questionnaire ( FFQS ) Cognitive Affective Regulation Scale ( CAMS-R ) . There also secondary endpoint use gain insight potential effect modification mediation . Secondary analysis also include proportion day use alcohol/drugs , crave , psychosocial function emotional regulation . Participants assess weekly throughout intervention , end intervention 3- 6- month follow-up .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<criteria>Women 18 65 year age enrol Charleston Center ( CC ) intensive outpatient New Life program treatment . Able comprehend English . Meets fifth edition Diagnostic Statistical Manual V ( DSM V ) criteria current alcohol substance use disorder use alcohol/substances 30 day prior clinic treatment entry . Meets DSM V criterion current PTSD score great equal 25 CAPS 5.0 . Participants may also meet criterion mood anxiety disorder . Participants psychotropic medication mood anxiety disorder must stabilize medication least 4 week therapy initiation . Able adequately provide informed consent function intellectual level sufficient allow accurate completion assessment instrument . Willing commit 8 therapy session , baseline , weekly followup assessment . Current primary psychotic thought disorder ( i.e . Schizophrenia schizoaffective disorder , mania ) , major depression suicidal ideation , dissociative identity disorder and/or homicidal ideation . Present serious suicide risk , severe depression , likely require hospitalization course study . In ongoing therapy PTSD either within outside CC , willing discontinue therapy duration study therapy , Unstable medical condition one may require hospitalization course study . Women pregnant planning become pregnant .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Mindfulness</keyword>
	<keyword>Comorbid PTSD SUD</keyword>
	<keyword>Meditation</keyword>
</DOC>